Facebook-f Twitter Linkedin Youtube
SUBSCRIBE
Facebook-f Twitter Linkedin Youtube
SUBSCRIBE

Beyond the Guidelines for CMV: Clinical Perspectives on Challenging Cases Post-Transplant: A Clinical Forum®

Program Overview

Cytomegalovirus (CMV) is a prevalent and potentially life-threatening viral infection in transplant recipients. CMV management in this high-risk population continues to evolve with updated guidelines and newer, less toxic antiviral therapy.

During this activity, faculty will discuss state-of-the-art strategies for preventing and treating CMV in transplant patients, sharing practical insights from challenging cases encountered in their clinical practice.

Credit Expired
PARTICIPATE

Target Audience

Infectious disease, transplantation, internal medicine, and nephrology clinicians

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Apply treatment strategies for cytomegalovirus (CMV) infection in transplant recipients
  • Identify refractory or drug-resistant CMV in transplant recipients in the post-transplant setting
  • Integrate new antiviral therapies into management regimens for transplant recipients, including those who develop refractory or drug-resistant CMV

Activity Faculty

62-24-1543-SM-002 ID Week Blumberg RGB

Emily A. Blumberg, MD

Specialist, Transplant Infectious Diseases
Director, Transplant Infectious Diseases
Program Director, Infectious Diseases Fellowship
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, PA

62-24-1543-SM-002 ID Week Faculty Pereira RGB

Marcus R. Pereira, MD, MPH, FAST 

Associate Professor, Medicine
Medical Director, Transplant Infectious Diseases Program
Columbia University Irving Medical Center
NewYork-Presbyterian Hospital
New York, NY

Featured RMEI CE Activities

VIEW All RMEI CE ACTIVIES

Subscribe

Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources

Join Now!